MétaCan
Menu
Back to cohort
Record W1529970569 · doi:10.4212/cjhp.v61i1.6

Stability of Bortezomib Reconstituted with 0.9% Sodium Chloride at 4°C and Room Temperature (23°C)

2009· article· en· W1529970569 on OpenAlexaffvenue
Scott E. Walker, D. Milliken, Shirley Law

Bibliographic record

VenueThe Canadian Journal of Hospital Pharmacy · 2009
Typearticle
Languageen
FieldHealth Professions
TopicSafe Handling of Antineoplastic Drugs
Canadian institutionsHealth Sciences CentreCancer Care OntarioSunnybrook Health Science Centre
Fundersnot available
KeywordsVialBortezomibChemistryChromatographySodiumRegimenMedicineSurgeryMultiple myelomaInternal medicineOrganic chemistry

Abstract

fetched live from OpenAlex

ABSTRACT Background : The bortezomib product monograph indicates that after reconstitution, the drug may be stored for up to 3 h in a syringe, and the total storage time for the reconstituted material must not exceed 8 h when exposed to normal indoor lighting. Given the product packaging and vial size, as well as the currently recommended dosage regimen (which, for a clinic treating between 1 and 10 patients daily, entails using about half a vial each day), there is potential for substantial wastage, about $13,000 for a 5-cycle course of bortezomib therapy for a single patient. The aim of this study was to evaluate the stability of bortezomib (3.5-mg vials) reconstituted with 3.5 mL of 0.9% sodium chloride (NS) to produce a 1 mg/mL solution. Methods: On study day 0, six 3.5-mg vials of bortezomib were reconstituted with 3.5 mL NS per vial, to prepare solutions of 1.0 mg/mL. Three of the vials were stored in the refrigerator, and 3 were stored at room temperature. Concentration was measured and physical inspection was completed for each vial on study days 0, 1, 4, 8, 11, 15, 18, 21, 28, 34, and 42. The intervals between study days were consistent with the recommended dosage regimen, as published in the product monograph. Bortezomib concentrations were determined by a validated, stability-indicating, liquid chromatographic method. Results : All solutions remained clear and colourless. During the study period, all solutions retained more than 98% of the initial concentration, and the amount remaining on day 42 was greater than 98% (with 95% confidence). During the study period, the absolute deviation from the known concentration for standards and quality control samples averaged less than 4%, and analytical reproducibility within a day (by coefficient of variation) was high, with error on replicate analysis averaging less than 2%. Conclusions : Bortezomib, supplied in 3.5-mg vials and reconstituted with 3.5 mL NS, is physically and chemically stable for up to 42 days at 4°C or at room temperature. RESUME Historique : La monographie du bortezomib mentionne qu'apres reconstitution, le medicament peut etre conserve jusqu'a trois heures dans une seringue, mais que la duree totale de conservation du medicament reconstitue ne doit pas depasser huit heures si le produit est expose a un eclairage interieur normal. Vu le conditionnement du produit, le format des fioles et la posologie recommandee actuellement (qui, dans une clinique qui traite de 1 a 10 patients par jour, signifie l'emploi d'environ une demi-fiole par jour), le potentiel de gaspillage est considerable, et peut etre evalue a environ 13 000 dollars pour cinq cycles de traitement par le bortezomib pour un seul patient. L'objectif de cette etude etait d'evaluer la stabilite du bortezomib (en fioles de 3,5 mg) reconstitue avec 3,5 mL de chlorure de sodium a 0,9 % (NS) pour obtenir une concentration de 1 mg/mL. Methodes : Au jour 0, on a reconstitue six fioles de 3,5 mg de bortezomib avec 3,5 mL de NS par fiole, pour obtenir des solutions a 1.0 mg/mL. Trois des fioles ont ete entreposees au refrigerateur et les trois autres, a la temperature ambiante. La concentration a ete mesuree et une inspection physique a ete effectuee pour chaque fiole aux jours 0, 1, 4, 8, 11, 15, 18, 21, 28, 34 et 42 de l'etude. Les intervalles entre les jours de l'etude correspondaient a l'intervalle posologique recommande conformement a la monographie du produit. Les concentrations de bortezomib ont ete determinees au moyen d'une epreuve de stabilite par chromatographie liquide validee. Resultats : Toutes les solutions sont demeurees limpides et incolores. Pendant la periode de l'etude, toutes les solutions ont conserve plus de 98 % de leur concentration initiale, et il en etait de meme au jour 42 (intervalle de confiance a 95 %). Pendant la periode de l'etude, l'ecart absolu par rapport a la concentration connue des echantillons de reference et de controle de la qualite etait en moyenne inferieur a 4 %, et la reproductibilite analytique au cours d'une journee (selon le coefficient de variation) etait elevee, avec une erreur moyenne entre les mesures inferieure a 2 %. Conclusions : Les solutions obtenues a partir de la reconstitution du contenu d'une fiole de 3,5 mg de bortezomib avec 3,5 mL de NS sont physiquement et chimiquement stables pendant une periode allant jusqu'a 42 jours a une temperature de 4 °C ou a la temperature ambiante.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.052
Threshold uncertainty score0.991

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0010.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.027
GPT teacher head0.320
Teacher spread0.293 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations3
Published2009
Admission routes2
Has abstractyes

Explore more

Same venueThe Canadian Journal of Hospital PharmacySame topicSafe Handling of Antineoplastic DrugsFrench-language works237,207